Abstract
Apoptosis and epithelial-to-mesenchymal transition (EMT) have been implicated in a variety of biological processes, such as embryonic development, fibrosis and tumor progression. Transforming growth factor-β (TGF-β) can induce simultaneously both EMT and apoptotic response of epithelial cells. However, the underlying mechanism of these biological events remains not well understood. In the present study, we show that TGF-β1 induces apoptosis and EMT in AML-12 cells in a cell cycle-related manner, in which apoptosis and EMT took place at G2/M and G1/S phases, respectively. TGF-β1-induced apoptosis was correlated with different extent of caspase activation at different cell cycle phases. Interestingly, increased phosphorylation of protein kinase D (PKD) can be observed in G1/S phase in response to TGF-β1, and inhibition of PKD by inhibitor or by small interference RNA blocked EMT but not apoptosis. Our data suggest a previously unrecognized role of cell cycle state in the regulation of TGF-β-induced EMT and apoptosis, and demonstrate that PKD is involved in the TGF-β1-induced EMT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- EMT:
-
epithelial-to-mesenchymal transition
- TGF-β:
-
transforming growth factor-β
- PKD:
-
protein kinase D
References
Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL . (2002). J Cell Sci 115: 3193–3206.
Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL . (2000). J Biol Chem 275: 36803–36810.
Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME et al. (2001). Mol Biol Cell 12: 27–36.
Bollag WB, Dodd ME, Shapiro BA . (2004). Drug News Perspect 17: 117–126.
Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC . (1999). Oncogene 18: 4440–4449.
Derynck R, Akhurst RJ, Balmain A . (2001). Nat Genet 29: 117–129.
Grünert S, Jechlinger M, Beug H . (2003). Nat Rev Mol Cell Biol 4: 657–665.
Huber MA, Kraut N, Beug H . (2005). Curr Opin Cell Biol 17: 1–11.
Kalluri R, Neilson EG . (2003). J Clin Invest 12: 1776–1784.
Kennett SB, Roberts JD, Olden K . (2004). J Biol Chem 279: 3300–3307.
Lemonnier J, Ghayor C, Guicheux J, Caverzasio J . (2004). J Biol Chem 279: 259–264.
Liao JH, Chen JS, Chai MQ, Zhao S, Song JG . (2001a). Cell Res 11: 89–94.
Meier P, Finch A, Evan G . (2000). Nature 407: 796–801.
Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL . (2005). Science 307: 1603–1609.
Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P . (1999). J Cell Sci 112: 4557–4568.
Prigozhina NL, Waterman-Storer CM . (2004). Curr Biol 14: 88–98.
Prindull G, Zipori D . (2004). Blood 103: 2892–2899.
Prunier C, Howe PH . (2005). J Biol Chem 280: 17540–17548.
Qiang YW, Yao L, Tosato G, Rudikoff S . (2004). Blood 103: 301–308.
Schuster N, Krieglstein K . (2002). Cell Tissue Res 307: 1–14.
Storz P, Toker A . (2003). EMBO J 22: 109–120.
Thiery JP . (2002). Nat Rev Cancer 2: 442–454.
Thiery JP . (2003). Curr Opin Cell Biol 15: 740–746.
Twomey C, McCarthy JV . (2005). J Cell Mol Med 9: 345–359.
Valdés F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernandez M et al. (2002). Mol Cancer Res 1: 68–78.
Van Lint J, Rykx A, Vantus T, Vandenheede JR . (2002). Int J Biochem Cell Biol 34: 577–581.
Vega S, Morales AV, Ocaña OH, Valdés F, Fabregat I, Nieto MA . (2004). Genes Dev 18: 1131–1143.
Wakefield LM, Roberts AB . (2002). Curr Opin Genet Dev 12: 22–29.
Woods AJ, White DP, Caswell PT, Norman JC . (2004). EMBO J 23: 2531–2543.
Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL . (2004). Neoplasia 6: 603–610.
Yang Y, Zhao S, Song J . (2004). Int J Biochem Cell Biol 36: 223–234.
Zhao S, Yang Y, Song J . (2004). J Cell Physiol 199: 47–56.
Acknowledgements
We thank other members of the group for critical comments and many helpful discussions. This work was supported by grants from the National Natural Science Foundation of China (90408006 and 30421005) and Ministry of Science and Technology (2002CB513002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, Y., Pan, X., Lei, W. et al. Transforming growth factor-β1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 25, 7235–7244 (2006). https://doi.org/10.1038/sj.onc.1209712
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209712
Keywords
This article is cited by
-
Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence
Nature Communications (2022)
-
TGFβ signaling networks in ovarian cancer progression and plasticity
Clinical & Experimental Metastasis (2021)
-
Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells
Toxicological Research (2021)
-
Salt-inducible kinases (SIKs) regulate TGFβ-mediated transcriptional and apoptotic responses
Cell Death & Disease (2020)
-
Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression
Oncogene (2017)